98%
921
2 minutes
20
Although subtle barrier defects may facilitate allergen penetration, thereby enabling allergic sensitization, the relationship between sweating disturbance and skin barrier function is unknown. However, many studies on contact hypersensitivity in mice examined ear skin, which does not sweat, instead of the footpad, where sweating is uniquely present. In this study, we assessed whether sweat suppression in the footpad before hapten application provoked a skin barrier abnormality and reduced inflammatory thresholds to topical haptens. Mice without any genetic skin barrier dysfunction displayed markedly reduced inflammatory thresholds to haptens under transient sweat suppression before hapten application. Epicutaneously applied haptens penetrated the skin more robustly in the presence of sweat suppression compared with that in its absence, although this increase was abolished by exposure to high-humidity conditions. These mice displayed a subtle atopic dermatitis-like inflammation mediated by type 2 response-dominant inflammation and increased IgE responses, mimicking some events occurring in nonlesional atopic dermatitis skin in humans and in murine models. These lesions were dramatically attenuated by exposure to high-humidity conditions. In our model, hapten sensitization does not require mechanical injury, explaining why sensitization occurs through nonlesional atopic dermatitis skin. Awareness of the importance of preserving sweating responses is essential to prevent occupational contact dermatitis and atopic dermatitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jid.2024.02.025 | DOI Listing |
Front Pharmacol
August 2025
Department of Thoracic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Background: Primary focal hyperhidrosis (PFH) is a neurological dermatological disorder characterized by localized, excessive sweating. Current treatments have limitations, and postoperative compensatory hyperhidrosis remains a concern. Aquaporin 5 (AQP5) and neurologic factors such as Brain-Derived Neurotrophic Factor (BDNF) and Neuregulin-1 (NRG-1) are known to play key roles in sweat regulation.
View Article and Find Full Text PDFMikrochim Acta
August 2025
School of Mechanical Engineering, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District, Beijing, 100081, China.
This study presents a wearable multi-parameter electrochemical detection system (WMEDS) designed for the simultaneous monitoring of sweat biomarkers. The system integrates a microcontroller, a dual-mode signal acquisition circuit, and a low-power Bluetooth module. To address the non-stationary electrochemical signals, a preprocessing approach combining Savitzky-Golay filtering with Z-score-difference detection is employed.
View Article and Find Full Text PDFTher Adv Med Oncol
July 2025
Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade 11000, Serbia.
Background: Ovarian function suppression (OFS) and premature menopause lead to side effects that significantly worsen the quality of life for young women with hormone receptor-positive early breast cancer (HR+ eBC).
Objectives: We retrospectively analyzed the most common side effects of OFS and endocrine therapy (ET) in young women with HR+ eBC.
Design: This analysis was designed as a combined cohort study according to STROBE criteria.
Environ Health Prev Med
July 2025
Department of Health Policy and Management, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health (UOEH), Japan.
Background: Neck cooling is a practical method for preventing heat-related illness, however, its effectiveness in general workers is not well established. This study aimed to assess the effects of neck cooling on core body temperature and other physiological markers during exercise in a hot environment.
Methods: This randomized crossover trial was conducted from November 2023 to April 2024 at the Shared-Use Research Center at UOEH.
Riv Psichiatr
July 2025
Ex Dottorato Psichiatria Unimore, libero professionista.
Aim: The aim of the study was to define compliance and clinical efficacy on sleep disorders of a niaprazine-based galenic product; the active molecule marketed by an Italian pharmaceutical company since long time is no longer available as medical prescriptions are mostly oriented towards benzodiazepines and derivatives whose side effects in the medium-long term suggest however moderating and modulating their use. Niaprazine might therefore be prescribed in the interval drop out of benzodiazepines, or even as a primary therapeutic indication without significant side effects as widely confirmed by its previous historical use very frequent in children. Our research evaluated some aspects of prescribing pertinence and the clinical outcome results obtained with the use of galenic niaprazine in a cohort of patients with an indication for hypnoinducing treatment.
View Article and Find Full Text PDF